Xylem To Release First Quarter 2021 Financial Results On May 4, 2021

RYE BROOK, N.Y.–(BUSINESS WIRE)–Apr. 13, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, will release its first quarter 2021 results at 6:55 a.m. (ET) on Tuesday, May 4, 2021. At 10:00 a.m. (ET), Xylem’s senior management team will host a conference call with investors.... Read more

Bruker Announces First Quarter 2021 Preliminary Revenue

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2021 in a range of $549 – $554 million, representing reported revenue growth of approximately 30% to 31%, compared to the first quarter of 2020. Adjusting for the impact of foreign currency translation and acquisitions, Bruker estimates... Read more

Danaher Provides Update On First Quarter 2021 Financial Performance

WASHINGTON, April 13, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) announced today that it expects first quarter 2021 core revenue growth to be above the high-end of the Company’s previously communicated guidance range. For the quarter ended April 2, 2021, the Company expects revenue growth to be approximately 57.0% and non-GAAP core revenue growth... Read more

CORRECTING and REPLACING Illumina Named One of Singapore’s Best Employers

SINGAPORE–(BUSINESS WIRE)–First paragraph, second sentence of release should read: Illumina was second in Health Care and Equipment Services and placed 27th on the overall list. The updated release reads: ILLUMINA NAMED ONE OF SINGAPORE’S BEST EMPLOYERS Continues regional expansion with a focus on employees Illumina, Inc., today announced, for the second consecutive year, Illumina is... Read more

BioLife Solutions Appoints Two New Independent Board Directors

BOTHELL, Wash., April 6, 2021 /PRNewswire/ —BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has appointed Amy DuRoss, chief executive officer of Vineti, and Rachel Ellingson, senior vice president and chief strategy officer at Zimmer Biomet... Read more